Sign inGet started

NRXP

NRX Pharmaceuticals, Inc.CIK 1719406 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16

AI insights for NRXP PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for NRXP
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Casper Joseph MichaelChief Operating Officer1$0$02026-01-27
McBride DennisDirector1$0$02025-04-09
Flynn Patrick JohnDirector12$14.7K$02025-04-09
Hurvitz ChaimDirector12$1.05M$02025-04-09
Javitt Jonathan CDirector, 10% Owner10$6.00M$400.0K2025-04-09
ABRAMS MICHAEL SChief Financial Officer1$0$02025-02-07
Gorovitz AaronDirector6$11.2K$02023-08-30
Willard Stephen HCHIEF EXECUTIVE OFFICER1$58.5K$02022-12-16
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER7$69.4K$02022-12-16
Javitt Daniel C.10% Owner13$0$1.35M2022-11-30
Glied SharonDirector3$0$02022-10-21
Besthof RobertInterim CEO7$0$470.4K2022-03-08
Daigneault AlessandraGeneral Counsel & Secretary14$0$442.0K2021-09-02
McMaster Herbert RaymondDirector3$0$02021-08-26
Fricker WilliamCFO & Treasurer2$0$02021-05-24
Troy DanielDirector2$0$02021-05-24

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Casper Joseph MichaelChief Operating Officer A Award deriv2026-01-272026-02-17100,000— $0100,000SEC↗
Flynn Patrick JohnDirector A Award deriv2025-04-092025-09-1050,000— $050,000SEC↗
Hurvitz ChaimDirector A Award deriv2025-04-092025-09-1025,000— $025,000SEC↗
McBride DennisDirector A Award deriv2025-04-092025-09-1025,000— $025,000SEC↗
Javitt Jonathan CChairman and Chief Scientist A Award deriv2025-04-092025-09-10125,000— $0125,000SEC↗
ABRAMS MICHAEL SChief Financial Officer A Award deriv2025-02-072025-02-1150,000— $050,000SEC↗
Javitt Jonathan CChairman and Chief Scientist P Buy2024-12-172024-12-1840,000$1.17 $46.8K84,634SEC↗
Hurvitz ChaimDirector P Buy2023-08-302023-09-1170,000$0.29 $20.3K570,000SEC↗
Gorovitz AaronDirector P Buy2023-08-302023-09-1135,000$0.32 $11.2K105,000SEC↗
Javitt Jonathan CChief Scientist P Buy2023-08-232023-08-24100,000$0.33 $33.0K446,332SEC↗
Javitt Jonathan CChief Scientist P Buy2023-08-222023-08-23200,000$0.32 $64.0K346,332SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-12-162022-12-1930,000$1.10 $33.0K46,337SEC↗
Willard Stephen HCHIEF EXECUTIVE OFFICER P Buy2022-12-162022-12-1950,000$1.17 $58.5K50,000SEC↗
Javitt Jonathan CDirector, 10% Owner S Sale2022-12-072022-12-09400,000$1.00 $400.0K12,899,997SEC↗
Javitt Daniel C.10% Owner S Sale2022-11-302022-12-018,441$1.50 $12.7K9,634,793SEC↗
Javitt Daniel C.10% Owner S Sale2022-11-292022-12-0113,730$1.50 $20.6K9,643,234SEC↗
Flynn Patrick JohnDirector P Buy2022-11-282022-11-292,500$1.25 $3.1K37,709SEC↗
Flynn Patrick JohnDirector P Buy2022-11-282022-11-292,500$1.25 $3.1K37,709SEC↗
Flynn Patrick JohnDirector P Buy2022-11-282022-11-292,500$1.24 $3.1K40,209SEC↗
Flynn Patrick JohnDirector P Buy2022-11-282022-11-291,750$1.25 $2.2K1,750SEC↗
Flynn Patrick JohnDirector P Buy2022-11-282022-11-292,500$1.25 $3.1K40,209SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-11-288,716$1.12 $9.8K8,716SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-11-28600$1.10 $6609,316SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-11-287,021$1.11 $7.8K16,377SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-12-197,021$1.11 $7.8K16,337SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-12-198,716$1.12 $9.8K8,716SEC↗
VAN VOORHEES SETHCHIEF FINANCIAL OFFICER P Buy2022-11-252022-12-19600$1.10 $6609,316SEC↗
Hurvitz ChaimDirector P Buy2022-11-182022-11-2140,408$1.10 $44.4K500,000SEC↗
Hurvitz ChaimDirector P Buy2022-11-182022-11-2340,408$1.10 $44.4K500,000SEC↗
Javitt Daniel C.10% Owner S Sale2022-11-172022-11-1833,018$1.05 $34.7K9,656,964SEC↗
Hurvitz ChaimDirector P Buy2022-11-172022-11-21171,780$1.08 $185.5K459,592SEC↗
Hurvitz ChaimDirector P Buy2022-11-172022-11-23171,780$1.08 $185.5K459,592SEC↗
Javitt Daniel C.10% Owner S Sale2022-11-162022-11-18133,719$1.02 $136.4K9,689,982SEC↗
Hurvitz ChaimDirector P Buy2022-11-162022-11-21287,812$0.99 $284.9K287,812SEC↗
Hurvitz ChaimDirector P Buy2022-11-162022-11-23287,812$0.99 $284.9K287,812SEC↗
Javitt Daniel C.10% Owner S Sale2022-11-112022-11-1549,200$1.01 $49.7K9,823,701SEC↗
Hurvitz ChaimDirector A Award deriv2022-10-212022-11-21162,660— $0381,083SEC↗
Flynn Patrick JohnDirector A Award deriv2022-10-212022-11-22162,660— $0162,660SEC↗
Glied SharonDirector A Award deriv2022-10-212022-11-22162,660— $0228,097SEC↗
Gorovitz AaronDirector A Award deriv2022-10-212022-11-22162,660— $0162,660SEC↗
Javitt Daniel C.10% Owner S Sale2022-07-292022-08-02784,063$1.01 $791.9K9,872,901SEC↗
Javitt Daniel C.10% Owner G Gift2022-07-012022-07-052,000,000— $010,656,964SEC↗
Javitt Daniel C.10% Owner S Sale2022-06-072022-06-0786,459$0.65 $56.2K12,656,964SEC↗
Javitt Daniel C.10% Owner S Sale2022-06-062022-06-07115,657$0.67 $77.5K12,743,423SEC↗
Javitt Daniel C.10% Owner S Sale2022-06-032022-06-07243,596$0.70 $170.5K12,859,080SEC↗
Javitt Jonathan CChief Scientist P Buy2022-06-012022-06-02100,000$58.00 $5.80M146,332SEC↗
Javitt Jonathan CChief Scientist P Buy2022-06-012022-06-02100,000$0.58 $58.0K146,332SEC↗
Besthof RobertInterim CEO A Award deriv2022-03-082022-03-10100,000$2.61 $261.0K347,200SEC↗
Besthof RobertChief Comm. & Patient Office S Sale2021-09-152021-11-0240,000$11.76 $470.4K23,710SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-09-022021-11-027,502— $033,603SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-09-022021-11-0210,496— $026,101SEC↗
Daigneault AlessandraGeneral Counsel & Secretary C Conversion deriv2021-09-022021-11-0220,666$3.07 $63.4K28,934SEC↗
Daigneault AlessandraGeneral Counsel & Secretary C Conversion deriv2021-09-022021-11-0228,916$3.07 $88.8K71,924SEC↗
Daigneault AlessandraGeneral Counsel & Secretary M Exercise2021-09-022021-11-0218,420$3.07 $56.5K18,420SEC↗
Daigneault AlessandraGeneral Counsel & Secretary M Exercise2021-09-022021-11-0213,164$3.07 $40.4K31,584SEC↗
McMaster Herbert RaymondDirector A Award deriv2021-08-262021-11-0210,424— $010,424SEC↗
McMaster Herbert RaymondDirector C Conversion deriv2021-08-262021-11-0228,724$2.22 $63.8K16,362SEC↗
McMaster Herbert RaymondDirector M Exercise2021-08-262021-11-0218,300$2.22 $40.6K18,300SEC↗
Daigneault AlessandraGeneral Counsel & Secretary S Sale2021-08-232021-11-0233,715$13.11 $442.0K0SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-08-192021-11-0215,605— $015,605SEC↗
Daigneault AlessandraGeneral Counsel & Secretary C Conversion deriv2021-08-192021-11-0243,000$3.07 $132.0K100,840SEC↗
Daigneault AlessandraGeneral Counsel & Secretary M Exercise2021-08-192021-11-0227,395$3.07 $84.1K33,715SEC↗
Besthof RobertChief Comm. & Patient Office C Conversion deriv2021-08-162021-11-02100,000$0.20 $20.0K247,200SEC↗
Besthof RobertChief Comm. & Patient Office A Award deriv2021-08-162021-11-0236,290— $036,290SEC↗
Besthof RobertChief Comm. & Patient Office M Exercise2021-08-162021-11-0263,710$0.20 $12.7K63,710SEC↗
Javitt Daniel C.10% Owner G Gift2021-07-162021-11-02434,594— $013,102,676SEC↗
Javitt Daniel C.10% Owner G Gift2021-07-162021-11-02434,594— $013,537,270SEC↗
Besthof RobertChief Comm. & Patient Office A Award deriv2021-05-242021-06-10347,200— $0347,200SEC↗
Besthof RobertChief Comm. & Patient Office A Award deriv2021-05-242021-06-10347,200— $0347,200SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-05-242021-06-10143,840— $0143,840SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-05-242021-06-10148,800— $0148,800SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award deriv2021-05-242021-06-1049,600— $049,600SEC↗
Flynn Patrick JohnDirector A Award deriv2021-05-242021-06-10692,639— $0692,639SEC↗
Flynn Patrick JohnDirector A Award deriv2021-05-242021-06-10692,639— $0692,639SEC↗
Fricker WilliamCFO & Treasurer A Award deriv2021-05-242021-06-1099,200— $0198,400SEC↗
Fricker WilliamCFO & Treasurer A Award deriv2021-05-242021-06-1099,200— $099,200SEC↗
Glied SharonDirector A Award deriv2021-05-242021-06-1065,437— $065,437SEC↗
Hurvitz ChaimDirector A Award deriv2021-05-242021-06-10218,423— $0218,423SEC↗
Troy DanielDirector A Award deriv2021-05-242021-06-1065,437— $065,437SEC↗
Daigneault AlessandraGeneral Counsel & Secretary A Award2021-05-242021-06-106,320— $06,320SEC↗
Flynn Patrick JohnDirector A Award2021-05-242021-06-10362,332— $0362,332SEC↗
Flynn Patrick JohnDirector A Award2021-05-242021-06-1035,209— $035,209SEC↗
Flynn Patrick JohnDirector A Award2021-05-242021-06-1035,209— $035,209SEC↗
Glied SharonDirector A Award2021-05-242021-06-1013,168— $013,168SEC↗
Gorovitz AaronDirector A Award2021-05-242021-06-108,336— $08,336SEC↗
Gorovitz AaronDirector A Award2021-05-242021-06-108,336— $08,336SEC↗
Gorovitz AaronDirector A Award2021-05-242021-06-108,336— $08,336SEC↗
Gorovitz AaronDirector A Award2021-05-242021-06-1016,678— $016,678SEC↗
Hurvitz ChaimDirector A Award2021-05-242021-06-10208,443— $0208,443SEC↗
Hurvitz ChaimDirector A Award2021-05-242021-06-101,436,350— $01,436,350SEC↗
Javitt Daniel C.10% Owner A Award2021-05-242021-06-1013,971,864— $013,971,864SEC↗
Javitt Jonathan CChief Executive Officer A Award2021-05-242021-06-1046,332— $046,332SEC↗
Javitt Jonathan CChief Executive Officer A Award2021-05-242021-06-101,422,000— $01,422,000SEC↗
Javitt Jonathan CChief Executive Officer A Award2021-05-242021-06-1013,348,997— $013,348,997SEC↗
Troy DanielDirector A Award2021-05-242021-06-1043,093— $043,093SEC↗